The aim of this study was to investigate the chemical composition and anticancer effect of the leaf essential oil of Xylopia frutescens in experimental models. The chemical composition of the essential oil was analysed by GC/FID and GC/MS. In vitro cytotoxic activity of the essential oil was determined on cultured tumour cells. In vivo antitumour activity was assessed in Sarcoma 180-bearing mice. The major compounds identified were (E)-caryophyllene (31.48%), bicyclogermacrene (15.13%), germacrene D (9.66%), d-cadinene (5.44%), viridiflorene (5.09%) and a-copaene (4.35%). In vitro study of the essential oil displayed cytotoxicity on tumour cell lines and showed IC 50 values ranging from 24.6 to 40.0 lg/ml for the NCI-H358M and PC-3M cell lines, respectively. In the in vivo antitumour study, tumour growth inhibition rates were 31.0-37.5%. In summary, the essential oil was dominated by sesquiterpene constituents and has some interesting anticancer activity.
were used. Animals were housed in cages with free access to food and water. All animals were kept under a 12:12 h light-dark cycle (lights on at 6:00 a.m.). Animals were treated according to the ethical principles for animal experimentation of SBCAL (Brazilian Association of Laboratory Animal Science), Brazil. The Animal Studies Committee at the Federal University of Sergipe approved the experimental protocol (number 08/2012).
Plant material
X. frutescens leaves were collected in July 2011 at ''Mata do Junco'' in the Municipality of Capela, Sergipe State, Brazil, coordinates: S 10°57 0 52 00 W 37°04 0 65 00 . The species was identified by Dr. Ana Paula do Nascimento Prata. Voucher specimen number 22178 was deposited at the Herbarium of the Federal University of Sergipe, Brazil. The leaves were obtained from plants that were flowering and in fructification.
Hydrodistillation of the volatile constituents
X. frutescens leaves (200 g) were dried in an oven with circulating air at 40°C for 24 h and submitted to hydrodistillation for 4 h using a Clevenger-type apparatus (Amitel, São Paulo, Brazil). The essential oil was dried over anhydrous sodium sulfate and the percentage content (v/w) was calculated on the basis of the dry weight of plant material. The essential oils were stored in a freezer until analysis. Hydrodistillation was performed in triplicate.
GC analysis
GC analyses were carried out using a Shimadzu GC-17A fitted with a flame ionisation detector (FID) and an electronic integrator (Shimadzu, Kyoto, Japan). Separation of the compounds was achieved using a ZB-5MS fused capillary column (30 m Â 0.25 mm Â 0.25 lm film thickness; Phenomenex, Torrance, CA). Helium was the carrier gas at 1.0 ml/min flow rate. The column temperature program was: 40°C for 4 min, a rate of 4°C/min to 240°C, then a rate of 10°C/min to 280°C, and then 280°C for 2 min. The injector and detector temperatures were 250°C and 280°C, respectively. Samples (10 mg/ml in CH 2 Cl 2 ) were injected with a 1:50 split ratio. The injection volume was 0.5 ll. Retention indices were generated with a standard solution of n-alkanes (C 8 -C 20 ). Peak areas and retention times were measured by an electronic integrator. The relative amounts of individual compounds were computed from GC peak areas without FID response factor correction.
GC/MS analysis
GC/MS analyses were performed on a Shimadzu QP5050A GC/ MS system equipped with an AOC-20i auto-injector. A J&W Scientific DB-5MS fused capillary column (30 m Â 0.25 mm Â 0.25 lm film thickness; Agilent, Santa Clara, CA) was used as the stationary phase. MS data were taken at 70 eV with a scan interval of 0.5 s from m/z 40 to 500. All other conditions were similar to the GC analysis.
Identification of constituents
Essential oil components were identified by comparing the retention times of the GC peaks with standard compounds run under identical conditions and by comparison of retention indices (Van Den Dool & Kratz, 1963) and mass spectra (Adams, 2007) with those found in the literature, and by comparison of mass spectra with those stored in the NIST 107 and NIST 21, and Wiley 229 libraries.
In vitro cytotoxic activity assay
Tumour cell growth was determined by the ability of living cells to reduce the yellow dye 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to a purple formazan product, as described by Mossman (1983) . For all experiments, cells were seeded in 96-well plates (0.7 Â 10 5 cells/ml for adherent cells or 0.3 Â 10 6 cells/ml for suspended cells in 100 ll of medium). After 24 h, the drugs (0.78-50 lg/ml) were dissolved in pure DMSO and added to each well using HTS -High-Throughput Screening (Biomek 3000, Beckman Coulter Inc., Fullerton, CA). Then, the cells were incubated for 72 h. Doxorubicin (purity > 98%; Sigma Chemical Co., St. Louis, MO) was used as positive control. At the end of incubation, the plates were centrifuged, and the medium was replaced by fresh medium (150 ll) containing 0.5 mg/ml MTT. Three hours later, the formazan product was dissolved in 150 ll DMSO, and absorbance was measured using a multiplate reader (DTX 880 Multimode Detector, Beckman Coulter Inc.). The drug effects were expressed as the percentage of control absorbance of reduced dye at 595 nm.
In vivo antitumour activity assay
The in vivo antitumour effect was evaluated using Sarcoma 180 ascites tumour cells, following protocols previously described (Bezerra et al., 2006 (Bezerra et al., , 2008 Britto et al., 2012) . Ten-day-old Sarcoma 180 ascites tumour cells (2 Â 10 6 cells per 500 ll) were implanted subcutaneously into the left hind groin of mice. The essential oil was dissolved in 5% DMSO and given to mice intraperitoneally once a day for 7 consecutive days. At the beginning of the experiment, the mice were divided into four groups of 8-15 animals as follows: Group 1: animals treated by injection of vehicle 5% DMSO (n = 15); Group 2: animals treated by injection of 5-fluorouracil (5-FU, purity > 99%; Sigma Chemical Co.) (25 mg/kg/day) (n = 9); Group 3: animals treated by injection of the essential oil (50 mg/kg/day) (n = 8); Group 4: animals treated by injection of the essential oil (100 mg/kg/day) (n = 8). The treatments were started one day after tumour injection. The dosages were determined based on previous articles. On Day 8, the animals were sacrificed by cervical dislocation, and the tumours were excised and weighed. The drug effects were expressed as the percent inhibition of control.
Body mass loss, organ weight alterations and haematological analysis were determined at the end of the above experiment, as described by Britto et al. (2012) . Peripheral blood samples of the mice were collected from the retro-orbital plexus under light ether anaesthesia, and the animals were sacrificed by cervical dislocation. After sacrifice, the livers, kidneys and spleens were removed and weighed. In haematological analysis, total leukocyte counts were determined by standard manual procedures using light microscopy.
Statistical analysis
Data are presented as mean ± SEM/SD or half maximal inhibitory concentration (IC 50 ) values and their 95% confidence intervals (CI 95%) obtained by nonlinear regression. The differences between experimental groups were compared by ANOVA (analysis of variance) followed by the Student-Newman-Keuls test (p < 0.05). All statistical analyses were performed using the GraphPad program (Intuitive Software for Science, San Diego, CA).
Results and discussion
Hydrodistillation of X. frutescens leaves gave a colourless crude essential oil with a yield of 1.00 ± 0.09%, in relation to the dry weight of the plant material. As shown in Table 1 , it was possible to identify 34 compounds according to GC/MS and GC/FID analysis. The major compounds identified were (E)-caryophyllene (31.48%), bicyclogermacrene (15.13%), germacrene D (9.66%), d-cadinene (5.44%), viridiflorene (5.09%) and a-copaene (4.35%).
Some phytochemical studies on the stem bark and fruit from X. frutescens have been previously reported (Fournier et al., 1994; Leboeuf, Cave, Provost, Forgacs, & Janquemin, 1982; Melo, Cota, Oliveira, & Braga, 2001; Rocha, Silva, & Panizza, 1980; Sena-Filho, Duringer, Craig, & Schuler, 2008; Takahashi et al., 1995) . Particularly, germacrene D (24.2%), linalool (12.1%), b-pinene (8.0%), cis-sabinene hydrate (7.9%), trans-pinocarveol (7.8%), a-copaene (7.0%) and limonene (5.6%) were the major compounds identified in X. frutescens fruits (Sena-Filho et al., 2008) . a-Cubebene (25.2%) and d-cadinol (27.4%) were the compounds identified in its stem bark (Fournier et al., 1994) .
In genus Xylopia, bicyclogermacrene (36.5%), spathulenol (20.5%) and limonene (4.6%) were found in leaf essential oil of Xylopia aromatica. Xylopia cayennensis was composed of a-pinene (29.2%), b-pinene (16.5%), caryophyllene oxide (14.5%), bicyclogermacrene (14.5%), germacrene D (4.7%) and 1,8-cineole (4.5%). Xylopia emarginata was dominated by spathulenol (73.0%). For Xylopia nitida, c-terpinene (44.1%), p-cymene (13.7%), a-terpinene (12.6%) and limonene (11.3%) were identified (Maia et al., 2005) . In another study with leaf essential oil of X. aromatica the major compounds were a-pinene (26.1%), limonene (22.3%), bicyclogermacrene (20.4%) and b-pinene (19.0%) (Lago et al., 2003) . The essential oil of Xylopia sericea contained cubenol (57.4%) and a-epi-muurolol (26.1%) as the main compounds found in the leaves, while b-pinene (45.6%) and a-pinene (17.2%) were the main compounds found in the fruits (Pontes et al. (2007) . Tavares et al. (2007) investigated the chemical constituents from leaves of Xylopia langsdorffiana and observed that the major compounds were germacrene D (22.9%), trans-b-guaiene (22.6%), (E)-caryophyllene (15.7%) and a-pinene (7.3%). Quintans et al. (2013) analysed the chemical composition of three specimens of X. laevigata and observed that c-muurolene (0.60-7.99%), d-cadinene (1.15-13.45%), germacrene B (3.22-7.31%), a-copaene (3.33-5.98%), germacrene D (9.09-60.44%), bicyclogermacrene (7.00-14.63%) and (E)-caryophyllene (5.43-7.98%) were the major constituents in all samples of the essential oils. Although some chemical constituents present in the leaf oil of X. frutescens have been found in the essential oils from other Brazilian Xylopia species, recent studies as described above have demonstrated significant variations in the essential oils from the various species belonging to this genus. However, (E)-caryophyllene, bicyclogermacrene, germacrene D and a-and b-pinene, present in high concentration in most of the species investigated, appear to be the main compounds in the essential oil from the Brazilian Xylopia species.
Cytotoxicity was assessed against OVCAR-8 (ovarian adenocarcinoma), NCI-H358M (bronchoalveolar lung carcinoma) and PC-3M (metastatic prostate carcinoma) human tumour cell lines using the thiazolyl blue test (MTT) assay. Table 2 shows the obtained IC 50 values. The essential oil showed IC 50 values ranging from 24.6 to 40.0 lg/ml for the NCI-H358M and PC-3M cell lines, respectively. Doxorubicin, used as positive control, showed IC 50 values from 0.9 to 1.6 lg/ml for the NCI-H358M and PC-3M cell lines, respectively. According to Suffness and Pezzuto (1990) , those extracts presenting IC 50 values below 30 lg/ml in tumour cell line assays are considered promising for anticancer drug development. Thus, the essential oil obtained from X. frutescens presented promising results. Interestingly, cytotoxic activities have also been reported for the essential oils from some plants belonging to the Xylopia species, such as X. aethiopica (Asekun & Adeniyi, 2004) . These effects have been associated with a mixture of the major and minor constituents of these essential oils.
The leaf essential oil of X. frutescens was also able to inhibit tumour growth in mice in a dose-dependent manner. In the in vivo antitumour study, mice were subcutaneously transplanted with Sarcoma 180 cells and treated by the intraperitoneal route once a day for 7 consecutive days with the essential oil. The effects of the essential oil on mice implanted with Sarcoma 180 tumour cells are presented in Fig. 1 . On Day 8, the average tumour weight of the control mice was 1.93 ± 0.13 g. In the presence of the essential oil (50 and 100 mg/kg/day), the average tumour weights were 1.33 ± 0.19 and 1.20 ± 0.10 g, respectively. Tumour growth inhibition rates were 31.0-37.5%. 5-FU (25 mg/kg/day), used as positive control, reduced tumour weight by 63.2%. Systemic toxicological parameters were also examined in essential oil-treated mice using the experimental protocol described above. Table 3 shows the obtained data. No significant changes in the weight of livers, kidneys or spleens were seen in the essential oil-treated groups (p > 0.05). No significant changes in body weight gain were observed either (p > 0.05). In addition, essential oil-treated animals showed a significant increase in total numbers of circulating peripheral leukocytes, compared to the control group (p < 0.05). These results indicate that the essential oil increased the cell types involved in the primary defence mechanism. In contrast, 5-FU, used as positive control, reduced the body weights and spleen organ weights and induced a decrease in total leukocytes (p < 0.05).
In conclusion, the leaf essential oil of X. frutescens is characterised by the presence of (E)-caryophyllene, bicyclogermacrene, germacrene D, d-cadinene, viridiflorene and a-copaene. In addition, it exhibited in vitro and in vivo anticancer effects without an expressive toxicity. Further studies must be carried out to better understand the underlying mechanism involved in the anticancer activity of this essential oil.
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